DK1476012T3 - Transgene mus, der udtrykker PRKAG3 - Google Patents

Transgene mus, der udtrykker PRKAG3

Info

Publication number
DK1476012T3
DK1476012T3 DK03734810.9T DK03734810T DK1476012T3 DK 1476012 T3 DK1476012 T3 DK 1476012T3 DK 03734810 T DK03734810 T DK 03734810T DK 1476012 T3 DK1476012 T3 DK 1476012T3
Authority
DK
Denmark
Prior art keywords
prkag3
transgenic mice
mice expressing
human animals
transgenic non
Prior art date
Application number
DK03734810.9T
Other languages
English (en)
Inventor
Leif Andersson
Stefan Marklund
Original Assignee
Arexis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arexis Ab filed Critical Arexis Ab
Application granted granted Critical
Publication of DK1476012T3 publication Critical patent/DK1476012T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0362—Animal model for lipid/glucose metabolism, e.g. obesity, type-2 diabetes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Plant Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03734810.9T 2002-02-01 2003-01-31 Transgene mus, der udtrykker PRKAG3 DK1476012T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35343002P 2002-02-01 2002-02-01
PCT/IB2003/000912 WO2003063586A1 (en) 2002-02-01 2003-01-31 Transgenic animals expressing prkag3

Publications (1)

Publication Number Publication Date
DK1476012T3 true DK1476012T3 (da) 2010-05-31

Family

ID=27663211

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03734810.9T DK1476012T3 (da) 2002-02-01 2003-01-31 Transgene mus, der udtrykker PRKAG3

Country Status (8)

Country Link
US (2) US7214850B2 (da)
EP (1) EP1476012B1 (da)
AT (1) ATE458403T1 (da)
AU (1) AU2003209552B2 (da)
CA (1) CA2474007A1 (da)
DE (1) DE60331416D1 (da)
DK (1) DK1476012T3 (da)
WO (1) WO2003063586A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100806954B1 (ko) * 1999-09-10 2008-02-22 엥스티튀 나시오날 드 라 르세르쉬 아그로노미끄 ＡＭＰＫ의 γ사슬 변이체, 이를 코드하는 ＤＮＡ 서열 및 그의 용도
WO2003064466A1 (en) 2002-02-01 2003-08-07 Arexis Ab Variants of the alpha 1 subunit of human ampk
EP2867669B1 (en) 2012-06-27 2016-12-21 Metanomics Health GmbH Methods for identifying diabetes drugs
CN102978202A (zh) * 2012-10-10 2013-03-20 中国农业科学院北京畜牧兽医研究所 一种肌肉特异表达猪igf1基因的过表达载体
EP3224381B1 (en) 2014-11-25 2019-09-04 The Brigham and Women's Hospital, Inc. Method of identifying a person having a predisposition to or afflicted with a cardiometabolic disease
WO2016085876A1 (en) 2014-11-25 2016-06-02 The Broad Institute Inc. Clonal haematopoiesis
CN112795641A (zh) * 2021-02-09 2021-05-14 复旦大学附属中山医院 Scn5a中电压感受器突变位点r225q在扩心病基因检测中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5580722A (en) 1989-07-18 1996-12-03 Oncogene Science, Inc. Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease
AUPN745096A0 (en) 1996-01-08 1996-02-01 St. Vincent's Institute Of Medical Research Novel amp activated protein kinase
KR100806954B1 (ko) 1999-09-10 2008-02-22 엥스티튀 나시오날 드 라 르세르쉬 아그로노미끄 ＡＭＰＫ의 γ사슬 변이체, 이를 코드하는 ＤＮＡ 서열 및 그의 용도
US20020142310A1 (en) 2000-04-07 2002-10-03 Leif Andersson Variants of the human AMP-activated protein kinase gamma 3 subunit
WO2003064466A1 (en) 2002-02-01 2003-08-07 Arexis Ab Variants of the alpha 1 subunit of human ampk
US20050155091A1 (en) 2002-02-01 2005-07-14 Thomas Svensson Prkag3 gene promoter and uses thereof

Also Published As

Publication number Publication date
ATE458403T1 (de) 2010-03-15
US20080050767A1 (en) 2008-02-28
DE60331416D1 (de) 2010-04-08
CA2474007A1 (en) 2003-08-07
US20050172348A1 (en) 2005-08-04
AU2003209552B2 (en) 2007-09-27
US7858369B2 (en) 2010-12-28
US7214850B2 (en) 2007-05-08
EP1476012A1 (en) 2004-11-17
WO2003063586A1 (en) 2003-08-07
EP1476012B1 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
MX2007007602A (es) Agonistas del peptido 1 similar al glucagon, composiciones, metodos y usos.
Li et al. Biology and control of snail intermediate host of Schistosoma japonicum in the People's Republic of China
SG151315A1 (en) Human glp-1 mimetibodies, compositions, methods and uses
ATE401787T1 (de) Menschliches cd20 exprimierende transgene mäuse
WO2008011446A3 (en) Human glp-1 mimetibodies, compositions, methods and uses
MX2026002524A (es) Compuestos agonistas de gipr
NO20061931L (no) Humane EPO-mimetlsk hengselkjerne-etterlignere, sammensetninger, fremgangsmater og anvendelser
EP4248740A3 (en) Humanized sirpa-il15 knockin mice and methods of use thereof
CY1112383T1 (el) Αναστολεις της πρωτεϊνης ενεργοποιησης της 5-λιποξυγενασης (flap)
DE502005008790D1 (de) Substituierte phenylaminopyrimidine
EP1500698A4 (en) CELL WITH REDUCED OR DELETED ACTIVITY OF A PROTEIN INVOLVED IN GDP FUCOSET TRANSPORT
MX2009006892A (es) Uso de agonistas del receptor de peptido similar al glucagon de tipo 1 de accion prolongada para mejorar la sensibilidad a la insulina y los perfiles de lipidos.
WO2008076915A8 (en) Treatment of pigs with pcv2 antigen
EP1543158A4 (en) REGULATED APTAMER THERAPEUTICS
DK1476012T3 (da) Transgene mus, der udtrykker PRKAG3
DK2022786T3 (da) Middel mod mund- og klovsyge-virus til dyr, der hører til familien suidae eller får, og fremgangsmåde til forebyggelse eller behandling af mund- og klovsyge hos dyr, der hører til familien suidae eller får
EP1907575A4 (en) POLYMORPHISMS IN THE GENE OF THE MITOCHONDRIAL TRANSCRIPTION FACTOR A (TFAM) AND ITS ASSOCIATIONS WITH MEASUREMENTS OF THE DEPTH OF SICKNESS AND SUBCUTANEOUS FAT IN MEAT RINDER
EP1406917A4 (en) HUMAN ANALYTICAL MODELS FOR THE EVALUATION OF MEDICINAL PRODUCTS AND FOR TOXICOLOGICAL AND IMMUNOGENIC EXAMINATIONS
NO20075272L (no) Humane GLP-1 "mimetibodies", sammensetninger, fremgangsmater og anvendelser
AU2002368482A1 (en) Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure
MY157842A (en) Use of long-acting recombinant human soluble tumor necrosis factor ? receptor in manufacture of a medicament for the treatment and/or prophylaxis of hepatic failure
ITRM20040455A1 (it) Uso di una composizione comprendente cuoio per il trattamento del mal dell'esca e marciume radicale di tutte le piante.
Henry Efalizumab Effective in Treatment of Plaque Psoriasis
NO20052774D0 (no) Topiske preparater og bruk av disse for behandling av vannlevende dyr utsatt for desinfeksjon og vaksinasjon.
Ip Early Life Stress, Physiologic Reactivity, and the Development of Control